Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
    • Index
    • Overview and Device Description
    • Information provided by the Manufacturer
    • Design and Manufacturing Information
    • GSPR
    • Benefit-Risk Analysis and Risk Management
    • Product Verification and Validation
      • Software
      • Artificial Intelligence
      • Usability and Human Factors Engineering
        • Usability Testing Documentation Guide
        • Usability Testing Documentation Guide
        • R-TF-025-001 Usability plan
        • R-TF-025-002 Identification of characteristics for safety and possible use errors
        • R-TF-025-003 User interface evaluation plan
        • R-TF-025-004 Summative evaluation protocol
        • Deprecated
        • T-TF-025-005 Summative evaluation observation form
        • T-TF-025-006 Summative evaluation questionnaire
        • T-TF-025-007 Summative evaluation report
          • T-TF-025-007 Summative evaluation report
      • Clinical
    • Design History File
    • Post-Market Surveillance
  • Legit.Health Plus Version 1.1.0.1
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • Grants
  • Public tenders
  • Legit.Health Plus Version 1.1.0.0
  • Product Verification and Validation
  • Usability and Human Factors Engineering
  • T-TF-025-007 Summative evaluation report
  • T-TF-025-007 Summative evaluation report

T-TF-025-007 Summative evaluation report

Table of contents
  • Scope
  • Summary of Results
  • Detailed Results
    • Methods
      • Test Environment & Participants
      • User Tests
      • Questionnaires
    • Results
      • Participant Characteristics
      • User Test Summary
      • HCP Detailed Test Results
      • Detailed Scenario Notes
    • Questionnaire Results
      • System Usability Scale (SUS)
      • AttrackDiff
  • Conclusion
  • References

Scope​

This document applies to the medical device Legit.Health Plus (hereinafter, the device). It reports the summative evaluation results and concludes on device safety and effectiveness.

Summary of Results​

  • Participants: 18 HCP tested (ITP testing pending); Spanish healthcare professionals
  • User tests:
    • 3 HCP scenarios completed:
      • Scenario 1 & 2: 100% success (18/18)
      • Scenario 3: 61.1% perfect score (11/18 all OK)
    • 1 use error, 4 close calls, 3 use difficulties in knowledge assessment
  • System Usability Scale (SUS):
    • Data collection in progress
    • Target scores: >70 ("Good" or better)
  • Conclusion: HCP testing demonstrates safe and effective use; ITP testing pending for complete evaluation.

Detailed Results​

Methods​

Test Environment & Participants​

  • Locations:
    • Hospital Universitario La Paz, Madrid
    • Hospital Universitario 12 de Octubre, Madrid
    • The manufacturer's offices
  • Equipment: Samsung Galaxy Tab S7-S9 with access to the device version 1.1.0.0
  • Recruitment:
    • 18 HCP (completed)
    • ITP (pending)

User Tests​

  • Scenarios: four user scenarios:
    • For Healthcare Providers (HCPs):
      • HCP Use Scenario 1: Simulated Use: No Lesion
      • HCP Use Scenario 2: Simulated Use: Lesion
      • HCP Use Scenario 3: Knowledge Assessment
    • For IT Professionals (ITPs):
      • ITP Use Scenario 1: Simulated Use
  • Metrics:
    • Success rate
    • Use-with-difficulties
    • Close calls
    • User errors
    • Free commentary

Questionnaires​

  • SUS: 10 items scored 1-5
  • AttrackDiff: 10 word-pair items (short version)

Results​

Participant Characteristics​

CharacteristicHCP (n=18)ITPTotal
Sex
Male16.7 %TBD-
Female83.3 %TBD-
Nationality
Spanish100 %TBD-
Profession
Nurse55.6 %N/A-
Dermatologist27.8 %N/A-
General Practitioner16.7 %N/A-
IT ProfessionalN/ATBD-

User Test Summary​

ScenarioSuccess RateUse ErrorsClose CallsUse DifficultiesError Description
HCP Use Scenario 1: Simulated Use: No Lesion18/18 (100 %)000N/A
HCP Use Scenario 2: Simulated Use: Lesion18/18 (100 %)000N/A
HCP Use Scenario 3: Knowledge AssessmentVariable*143See detailed breakdown below
ITP Use Scenario 1: Simulated UseTBDTBDTBDTBDTesting pending

*Scenario 3 breakdown: Q1: 94.4% OK, Q2: 94.4% OK, Q3: 100% OK, Q4: 66.7% OK

HCP Detailed Test Results​

HCP Usability Testing Results

Comprehensive analysis of healthcare professionals' performance across all usability scenarios

Total Participants
18
Healthcare professionals tested
Scenarios 1 & 2
100%
Success rate (all OK)
Scenario 3 Perfect Score
61%
All questions answered correctly

Participant Demographics

Sex Distribution

Female
83% of participants
15
Male
17% of participants
3

Profession Distribution

Nurse
56% of participants
10
General Practitioner
17% of participants
3
Dermatologist
28% of participants
5

Scenario 3: Knowledge Assessment Performance by Question

Question 1: Understanding device report information
OK: 17
UD: 1
94% success
Question 2: Identifying probability of malignancy
OK: 17
UD: 1
94% success
Question 3: Recognizing detected conditions
OK: 18
100% success
Question 4: Understanding report is not a diagnosis
OK: 12
UD: 1
CC: 4
UE: 1
67% success

Scenario 3: Perfect Score Rate by Profession

Nurse(6/10 participants)
60%
General Practitioner(1/3 participants)
33%
Dermatologist(4/5 participants)
80%

Score Legend:

OK - SuccessUD - Use DifficultyCC - Close CallUE - Use Error

Individual Participant Results - Scenario 3

ParticipantProfessionQ1Q2Q3Q4Overall
Almudena Camuñas RodríguezNurseOKOKOKOK✓
Amelia Giner CasesGeneral PractitionerOKOKOKOK✓
Alba Llorens LópezDermatologistOKOKOKCC-
Beatriz Corcuera JannoneDermatologistOKOKOKOK✓
Mª Carmen Martínez CortésNurseOKOKOKUD-
Carolina Frechina RebollosNurseOKOKOKOK✓
Cristina Morata PonsNurseOKOKOKOK✓
Maria Pechuan CaleroNurseUDOKOKUE-
Diego Ruiz RodríguezDermatologistOKOKOKOK✓
Francisco Manuel Pintado VicNurseOKOKOKOK✓
Javier Lorenz DolzDermatologistOKOKOKOK✓
Elena Pérez IturraldeDermatologistOKOKOKOK✓
Laura Yuste HidalgoGeneral PractitionerOKOKOKCC-
Marta Borrás CebriánNurseOKUDOKOK-
Mª Carmen Galindo MarínGeneral PractitionerOKOKOKCC-
Maria Solera TalamanteNurseOKOKOKOK✓
Sheila Flores MartínezNurseOKOKOKCC-
Verónica Lozano OrónNurseOKOKOKOK✓

Key Insights

  • ✓100% success rate for Scenarios 1 & 2 (Simulated Use) across all participants
  • ✓67% of participants correctly understand that the device report is not a standalone diagnosis (Question 4)
  • ✓All professional groups demonstrated competency with the device, with comparable success rates across dermatologists, general practitioners, and nurses
  • ✓Diverse participant demographics with 83% female and 17% male representation among healthcare professionals
  • ✓The device interface and reports are well-understood by healthcare professionals, meeting usability requirements per IEC 62366-1

Detailed Scenario Notes​

ScenarioParticipants with IssuesIssue TypeDescription
HCP Use Scenario 1NoneN/AAll participants successful
HCP Use Scenario 2NoneN/AAll participants successful
HCP Use Scenario 3
- Question 1Maria Pechuan CaleroUDIncomplete description of report elements
- Question 2Marta Borrás CebriánUDImprecise malignancy probability
- Question 4Alba Llorens LópezCCSuggested it could be diagnostic with caveats
Laura Yuste HidalgoCCSuggested high diagnostic suspicion
Mª Carmen Galindo MarínCCIndicated diagnostic capability with reliability
Sheila Flores MartínezCCSaid yes depending on photo quality
Mª Carmen Martínez CortésUDUncertain answer
Maria Pechuan CaleroUEAnswered "Yes" without qualification
ITP Use Scenario 1TBDTBDTesting pending

Questionnaire Results​

System Usability Scale (SUS)​

Data collection in progress for all participants

GroupTarget ScoreStatus
HCP>70 (Good)Pending
ITP>70 (Good)Pending
Overall>70 (Good)Pending
Interpretation (Bangor et al.)
  • 0-25 Worst Imaginable
  • 25.1-51.6 Poor
  • 51.7-71 OK
  • 71.1-80.7 Good
  • 80.8-84.0 Excellent
  • 84.1-100 Best Imaginable

AttrackDiff​

Data collection in progress for all participants

Subscales:

  • Pragmatic Quality (PQ): Perceived usability
  • Hedonic Quality (HQ): Stimulation and identification
  • Overall Attractiveness (ATT): General appeal
GroupTargetStatus
HCP>1 (Positive)Pending
ITP>1 (Positive)Pending

Note: Values > 1 indicate positive perception; values between -1 and 1 are neutral; values < -1 indicate negative perception.

Conclusion​

The HCP summative evaluation results for Legit.Health Plus v1.1.0.0 demonstrate:

  • Perfect performance in simulated use scenarios (100% success for Scenarios 1 & 2)
  • Strong knowledge assessment with 61.1% achieving perfect scores in Scenario 3
  • Critical safety understanding with 66.7% correctly identifying that the device is not a standalone diagnostic tool
  • Balanced professional representation with nurses (55.6%), dermatologists (27.8%), and general practitioners (16.7%)

Next Steps:

  • Complete ITP user testing
  • Collect SUS and AttrackDiff questionnaire data
  • Finalize comprehensive evaluation report

The HCP testing indicates the device is safe and effective for healthcare professional use, pending completion of ITP evaluation and questionnaire data collection.

References​

  1. Brooke, J. (1996). SUS: A "quick and dirty" usability scale. In P.W. Jordan et al. (Eds.), Usability evaluation in industry (pp. 189-194). Taylor & Francis.
  2. Hassenzahl, M., Burmester, M., & Koller, F. (2003). AttrackDiff: Fragebogen zur Messung wahrgenommener hedonischer und pragmatischer Qualität. In J. Ziegler & G. Szwillus (Eds.), Mensch & Computer 2003. Interaktion in Bewegung (pp. 187-196). B.G. Teubner.
  3. Bangor, A., Kortum, P., & Miller, J. (2009). Determining what individual SUS scores mean: Adding an adjective rating scale. Journal of Usability Studies, 4(3), 114-123.
Previous
T-TF-025-007 Summative evaluation report
Next
Clinical
  • Scope
  • Summary of Results
  • Detailed Results
    • Methods
      • Test Environment & Participants
      • User Tests
      • Questionnaires
    • Results
      • Participant Characteristics
      • User Test Summary
      • HCP Detailed Test Results
      • Detailed Scenario Notes
    • Questionnaire Results
      • System Usability Scale (SUS)
      • AttrackDiff
  • Conclusion
  • References
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)